Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion

Published:2016-03-08 Issue:10 Volume:315 Page:984
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Sharfstein Joshua M.¹,Psaty Bruce M.²

Affiliation:

1. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

2. Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle3Group Health Research Institute, Group Health Cooperative, Seattle, Washington

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manejo interdisciplinario de la obesidad y el sobrepeso en rehabilitación cardiaca: revisión de la Sociedad Mexicana para el Cuidado del Corazón;Archivos de Cardiología de México;2023-06-15

2. Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview;Diabetes, Metabolic Syndrome and Obesity;2023-06

3. Governance of adaptive platform trials;Wellcome Open Research;2023-03-28

4. Data Safety and Monitoring Boards Should Be Required for Both Early- and Late-Phase Clinical Trials;JACC: Basic to Translational Science;2021-11

5. New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists;Minerva Endocrinologica;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP